Kezar Life Sciences, Inc. (KZR)
7.29
0.00 (0.00%)
USD |
NASDAQ |
May 29, 16:00
Kezar Life Sciences EPS Diluted (Quarterly) : -0.7838 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovelStem International Corp. | -0.0012 |
| Brainstorm Cell Therapeutics, Inc. | -0.1928 |
| Summit Therapeutics, Inc. | -0.2443 |
| Protara Therapeutics, Inc. | -0.309 |
| Clene, Inc. | -0.6949 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.756M |
| Total Expenses (Quarterly) | 5.756M |
| Enterprise Value | -11.14M |
| Earnings Yield | -84.73% |
| Normalized Earnings Yield | -74.78 |